Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Developmental Dynamics : an Official Publication of the American Association of Anatomists|July 9, 2005
A potential role for beta- and gamma-crystallins in the vascular remodeling of the eyeCheng Zhang, Peter Gehlbach, Celine Gongora, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 6, 2020
Liquid chromatography-tandem mass spectrometric assay for the quantification of CDK4/6 inhibitors in human plasma in a clinical context of drug-drug interactionFanny Leenhardt, Matthieu Gracia, Catherine Perrin, et al.
Molecular Cancer Therapeutics|August 21, 2013
Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pumpThibault Mazard, Annick Causse, Joelle Simony, et al.
Pharmaceutics|April 23, 2022
Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug-Drug Interactions Are the Usual SuspectsFanny Leenhardt, Frédéric Fiteni, Ludovic Gauthier, et al.
Translational Oncology|June 5, 2013
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation LoadFlorent Mouliere, Safia El Messaoudi, Celine Gongora, et al.
European Journal of Cell Biology|March 1, 2011
A developmental defect in astrocytes inhibits programmed regression of the hyaloid vasculature in the mammalian eyeCheng Zhang, Laura Asnaghi, Celine Gongora, et al.
Mabs|April 20, 2021
Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer modelsEmilia Rabia, Véronique Garambois, Julie Hubert, et al.
Cancer Research|April 17, 2019
Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (ATR) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal CancerEve Combès, Augusto F Andrade, Diego Tosi, et al.
Cancer Research|October 1, 2025
Targeting SUV4-20H Epigenetic Enzymes Enhances Topoisomerase II Poisoning in Prostate CancerFatima Alhourani, Marine Tauziet, Margaux Ayeul, et al.
Nature Medicine|March 25, 2014
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNAAlain R Thierry, Florent Mouliere, Safia El Messaoudi, et al.
Pageof 3